Improving patient outcomes in heart failure: evidence and barriers
Open Access
- 1 September 2000
- Vol. 84 (90001) , 8i-10
- https://doi.org/10.1136/heart.84.suppl_1.i8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- ACE inhibitors still the drug of choice for heart failure—and moreThe Lancet, 1999
- Is the prognosis of heart failure improving?European Journal of Heart Failure, 1999
- Changing patterns of investigation and treatment of cardiac failure in hospital.Heart, 1996
- Prevalence, aetiology and management of heart failure in general practice.1996
- Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: are we ignoring the evidence?QJM: An International Journal of Medicine, 1996
- Noncompliance With Congestive Heart Failure Therapy in the ElderlyArchives of internal medicine (1960), 1994
- Cardiac transplantationJournal of the American College of Cardiology, 1993
- A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart FailureNew England Journal of Medicine, 1991
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986